Community Healthcare Trust vs Universal Health Realty Income Trust
CHCT and UHT side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CHCT and UHT compare
Universal Health Realty Income Trust is the larger company, worth 1.4 times as much as Community Healthcare Trust ($532M against $374M).
On earnings, Community Healthcare Trust is cheaper: it trades at 19.5× trailing earnings, against 27.5× for Universal Health Realty Income Trust.
Community Healthcare Trust grew revenue faster over the last twelve months (5.7% versus 0.75% for Universal Health Realty Income Trust).
Universal Health Realty Income Trust keeps more of each dollar of sales as profit, with a net margin of 19.4% compared with 16.8% at Community Healthcare Trust.
Both pay dividends: Community Healthcare Trust yields 13.5% and Universal Health Realty Income Trust 7.8%.
Universal Health Realty Income Trust scores higher on the StockData Score (16 against 13 for Community Healthcare Trust), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CHCT | UHT |
|---|---|---|
| Size and price | ||
| Market cap | $374M | $532M |
| Share price | $13.06 | $38.25 |
| Change, 1 year | −9.5% | 5.1% |
| Change, 5 years | −72.6% | −36.2% |
| Beta (5Y) | 0.68 | 0.57 |
| Employees | 35 | – |
| StockData Score | ||
| Total score | 13 | 16 (better) |
| Valuation score | 5 (better) | 3 |
| Growth score | 1 | 1 |
| Performance score | 3 | 3 |
| Health score | 0 | 5 (better) |
| Dividend score | 4 | 4 |
| Valuation | ||
| P/E | 19.5× (better) | 27.5× |
| P/S | 3.0× (better) | 5.4× |
| P/B | 0.9× (better) | 3.7× |
| EV/EBITDA | – | 8.2× |
| Fair value | $24.20 | $40.14 |
| Margin of safety | 46.0% (better) | 4.7% |
| Growth | ||
| Revenue growth (TTM) | 5.7% (better) | 0.75% |
| Revenue growth, 5Y average | 9.9% (better) | 4.9% |
| Net income growth (TTM) | – | 7.5% |
| EPS growth (TTM) | – | 7.8% |
| EPS growth, 5Y average | −36.9% | −2.1% (better) |
| Profitability | ||
| Operating margin | – | 35.3% |
| Net margin | 16.8% | 19.4% (better) |
| Return on equity | 4.9% | 12.5% (better) |
| Return on invested capital | – | 18.7% |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Altman Z-score | 0.51 | 3.29 (better) |
| Piotroski F-score | 5 | 5 |
| Dividends and buybacks | ||
| Dividend yield | 13.5% (better) | 7.8% |
| Payout ratio | 260% | 215% |
| Years of dividend growth | 10 | 15 (better) |
| Dividend growth, 5Y average | 2.3% (better) | 1.4% |
| Shareholder yield | 13.5% (better) | 7.8% |
| Ownership | ||
| Held by institutions | 80.8% | 62.0% |
| Held by insiders | 6.8% | 2.7% |
| Insider net buying, 12 months | $332K (better) | $0 |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 3.2% | 2.8% |
Go deeper
- CHCT stock overview
- CHCT income statement
- CHCT valuation and score
- UHT stock overview
- UHT income statement
- UHT valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.